Table 2.
Health-related characteristics in first stroke patients referred to specialized cognitive rehabilitation (n: 91) in relation to satisfaction with sexual life
| Health-related characteristics | Total, n:91 | Satisfied sexual life, n:30 | Dissatisfied sexual life, n:61 | P value |
|---|---|---|---|---|
| Time since stroke (mo) median (range) | 24.0 (3-170) | 22.5 (3-170) | 24.0 (4-130) | .99 |
| Classification of stroke, n (%) | ||||
| Ischemic | 62 (68.1) | 19 (63.3) | 43 (70.5) | .52 |
| Hemorrhage | 11 (12.1) | 3 (10.0) | 8 (13.1) | |
| Subarachnoid hemorrhage | 18 (19.8) | 8 (26.7) | 10 (16.4) | |
| Location of stroke (n = 89), n (%) | ||||
| Right hemisphere | 35 (39.3) | 15 (50.0) | 20 (33.9) | .33 |
| Left hemisphere | 35 (39.3) | 8 (26.7) | 27 (45.8) | |
| Bilateral hemisphere | 10 (11.2) | 4 (13.3) | 6 (10.2) | |
| Cerebellum | 9 (10.1) | 3 (10.0) | 6 (10.2) | |
| Global disability (mRS*), n (%) | ||||
| Slightly (score 2) | 82 (90.1) | 27 (90.0) | 55 (90.2) | 1. |
| Moderate (score 3) | 9 (9.9) | 3 (10.0) | 6 (9.8) | |
| Motor impairment, n (%) | 37 (40.7) | 10 (33.3) | 27 (44.3) | .44 |
| None | 54 (59.3) | 20 (66.7) | 34 (55.7) | .06 |
| Mild | 21 (23.1) | 8 (26.7) | 13 (21.3) | |
| Moderate | 11 (12.1) | 0 (0) | 11 (18.0) | |
| Severe | 5 (5.5) | 2 (6.7) | 3 (4.9) | |
| Spasticity, n (%) | 15 (16.5) | 4 (13.3) | 11 (18.0) | .77 |
| Bladder dysfunction, n (%) | 22 (24.2) | 7 (23.3) | 15 (24.6) | 1. |
| Bowel dysfunction, n (%) | 6 (6.6) | 2 (6.7) | 4 (6.6) | 1. |
| Pain VAS scale 0-10 (score >3 = moderate/severe), n (%) | 34 (37.4) | 12 (40.0) | 22 (36.1) | .89 |
| Sleep problem, n (%) | 40 (44.0) | 8 (26.7) | 32 (52.5) | .035 |
| Fatigue, n (%) | 81 (89.0) | 28 (93.3) | 53 (86.9) | .49 |
| Communication disorders†, n (%) | 20 (22.0) | 8 (26.7) | 12 (19.7) | .63 |
| Visual impairments, n (%) | 14 (15.4) | 5 (16.7) | 9 (14.8) | 1. |
| Comorbidities, n (%) | 74 (81.3) | 25 (83.3) | 49 (80.3) | .95 |
| Number of comorbidities, median (range) | 2.0 (0-10) | 1.0 (0-4) | 2.0 (0-10) | .07 |
| Hypertension | 20 (22.0) | 3 (10.0) | 17 (27.9) | .09 |
| Musculoskeletal | 17 (18.7) | 5 (16.7) | 12 (19.7) | .95 |
| Heart diseases | 9 (9.9) | 1 (3.3) | 8 (13.1) | .26 |
| Other brain diseases | 9 (9.9) | 2 (6.7) | 7 (11.5) | .71 |
| Epilepsy | 8 (8.8) | 2 (6.7) | 6 (9.8) | 1. |
| Diabetes | 4 (4.4) | 0 | 4 (6.6) | .30 |
| Other somatic diagnoses‡ | 39 (42.9) | 11 (36.7) | 28 (45.9) | .54 |
| Psychiatric diagnoses§ | 10 (11.0) | 4 (13.3) | 6 (9.8) | .72 |
| Medication, n (%) | 80 (87.9) | 27 (90.0) | 53 (86.9) | 1. |
| Number of medications, median (range) | 3.0 (0-15) | 3.0 (0-11) | 4.0 (0-15) | .17 |
| Antithrombotic agents/anticoagulants | 58 (63.7) | 18 (60.0) | 40 (65.6) | .77 |
| Statins | 43 (47.3) | 12 (40.0) | 31 (50.8) | .45 |
| Antihypertensive | 32 (35.2) | 7 (23.3) | 25 (41.0) | .15 |
| Antidepressants | 20 (22.0) | 5 (16.7) | 15 (24.6) | .55 |
| Antiepileptic drugs | 18 (19.8) | 5 (16.7) | 13 (21.3) | .81 |
| PDE-5 inhibitors (n = 58) | 6 (10.3) | 0 | 6 (9.8) | .17 |
| Other medicationsǁ | 58 (63.7) | 16 (53.3) | 36 (59.0) | .77 |
| Lifestyle risk factors¶, n (%) | 29 (31.9) | 8 (26.7) | 21 (34.4) | .61 |
| HADS-A♯, sum score ≥8, n (%) | 31 (34.1) | 5 (16.7) | 26 (42.6) | .026 |
| HADS-D♯, sum score ≥8, n (%) | 23 (25.3) | 4 (13.3) | 19 (31.1) | .11 |
Bold figures indicate significance.
⁎
mRS=modified Rankin Scale.
†
Primarily expressive communication disorders (word finding difficulties).
‡
Migraine, asthma, hypothyreosis and diagnoses with ≤4 patients affected.
§
ADHD+bipolar/personality disorder/PTSD (n:4), Bipolar (n:2), PTSD (n:3), Personality disorder (n:1).
ǁ
Pain killers, sleep medications, proton pump inhibitors, antiallergenic and medications used by ≤4 patients.
¶
Overweight (n:13), smoking (n:12) and substance use (n:5).
♯
HADS=Hospital Anxiety and Depression Scale, HADS-A: subscale anxiety, HADS-D: subscale depression.